Lancaster University intranasal vaccine offers promise to block COVID-19 where it starts

Research by Lancaster University scientists to create a COVID-19 vaccine which can be administered through the nose has taken a significant step forward. The pre-clinical animal trials of the intranasal vaccine showed a reduction in both the impact of the disease itself and transmission of the virus.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news